On the Viability of Tadalafil-Based 18F‑Radiotracers for In Vivo Phosphodiesterase 5 (PDE5) PET Imaging

• Justin J. Bailey,
• Melinda Wuest,
• Tamara Bojovic,
• Travis Kronemann,
• Carmen Wängler,
• Björn Wängler,
• Frank Wuest,
• Ralf Schirrmacher

Affiliations

Justin J. Bailey

Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada

Melinda Wuest

Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada

Tamara Bojovic

Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada

Travis Kronemann

Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada

Carmen Wängler

‡Biomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany

Björn Wängler

§Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany

Frank Wuest

Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada

Ralf Schirrmacher

Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada